HOLLY WHITE: Open Payments
NPI 1689063836 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 91 payments from 18 companies in 2025. Trend: 2023 $2,470 · 2024 $2,145 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $305 |
| ABBVIE INC. | 16 | $250 |
| PFIZER INC. | 21 | $183 |
| Novo Nordisk Inc | 9 | $158 |
| Amgen Inc. | 13 | $148 |
| Lilly USA, LLC | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
Products named: FARXIGA, QULIPTA, Wegovy, OTEZLA, MOUNJARO, PREVNAR 20, NURTEC ODT, CAPLYTA.
Industry payments across VA — which companies pay providers there.
